AMGN
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FAMGN.O%2Fkey-developments%2Farticle%2F2526985&ei=oIaaUtD9BYSQ0QGK1wE&usg=AFQjCNHwifXLZjVqAfzolBt813ScR8NljA
Amgen, Inc. To Acquire Mustafa Nevzat Pharmaceuticals
Wednesday, 25 Apr 2012 02:33am EDT
Amgen, Inc. and Mustafa Nevzat Pharmaceuticals (MN) announced an agreement under which Amgen will acquire 95.6% of shares in MN, a privately held Turkish pharmaceutical company, for an amount that values MN at USD700 million. The transaction has been approved by the Board of Directors of each company.Â 
